SCHEMBL29640901

SCHEMBL29640901

COc1ccc2c(c1)CN(c1nccc(-c3nccc(C#Cc4ccccc4C(=O)O)n3)n1)C2

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 4/20 0.41
HCRTR2 O43614 4/20 0.41
ROCK2 O75116 3/20 0.40
ROCK1 Q13464 2/20 0.40
SCN9A Q15858 2/20 0.35
PDE10A Q9Y233 1/20 0.35
NAMPT P43490 1/20 0.35
HCAR2 Q8TDS4 1/20 0.34
HSP90AB1 P08238 2/20 0.34
LMNA P02545 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
USP2 O75604 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CAMK1D Q8IU85 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29640913 0.93 ROCK2 (0.42) HCRTR1HCRTR2ROCK2ROCK1SCN9A
SCHEMBL29640909 0.91 SCN9A (0.42) HCRTR1HCRTR2ROCK2ROCK1SCN9A
SCHEMBL29640795 0.86 ROCK2 (0.42) HCRTR1HCRTR2ROCK2ROCK1PDE10A
SCHEMBL29627955 0.85 ROCK2 (0.42) HCRTR1HCRTR2ROCK2ROCK1SCN9A
SCHEMBL29627925 0.81 ROCK2 (0.43) HCRTR1HCRTR2ROCK2ROCK1SCN9A
SCHEMBL29627935 0.81 ROCK2 (0.52) HCRTR1HCRTR2ROCK2ROCK1SCN9A
SCHEMBL29627983 0.80 SCN9A (0.45) ROCK2ROCK1SCN9ANAMPT
SCHEMBL29640758 0.80 ROCK2 (0.41) HCRTR1HCRTR2ROCK2ROCK1PDE10A
SCHEMBL29627937 0.79 ROCK2 (0.54) ROCK2ROCK1
SCHEMBL29640451 0.79 ROCK2 (0.44) ROCK2ROCK1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502163-A Ethynylheterocycles as RHO-related coiled coil kinase (ROCK) inhibitors 安吉昂生物医药公司 2022-05-13 CN disclosed